Conclusion of Non-Exclusive Rebate Agreements under Section 130a (8) SGB V via an Open-House Model for the Active Substance Interferon beta-1b (WHO ATC Code: L03AB08)
About This Opportunity
TranslatedThis tender, originating from Germany and published on the TED (Tenders Electronic Daily) platform, seeks to establish non-exclusive agreements for medicines rebates under Section 130a, Paragraph 8 of the German Social Code Book V (SGB V). The procurement is structured as an 'open-house model' and specifically targets rebates for the active substance Interferon beta-1b, identified by the WHO ATC code L03AB08. The contracting authority is inviting pharmaceutical manufacturers and their authorized representatives to submit proposals. This procurement aims to secure cost-effective access to a specific pharmaceutical product by negotiating retrospective rebates based on sales volumes. The open-house model allows multiple qualified companies to participate and enter into agreements, fostering competition and potentially leading to better rebate conditions. The focus on Interferon beta-1b, a drug used in treating conditions like multiple sclerosis, indicates a specific therapeutic area of interest. The agreements will be non-exclusive, meaning the contracting authority can enter into similar agreements with other suppliers. The objective is to optimize pharmaceutical spending while ensuring the availability of essential medications.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Germany, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before May 31, 2028.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.
Description
Original language: GermanThis tender, originating from Germany and published on the TED platform, seeks to establish agreements for the exclusion of specific pharmaceutical rebates under Section 130a, Paragraph 8 of the German Social Code Book V (SGB V). The procurement pertains to the active substance Interferon beta-1b (WHO ATC Code: L03AB08) and will operate under an "open-house" model.
The contracting authority, managed by the Publications Office of the European Union, is inviting eligible pharmaceutical manufacturers and distributors to participate. The core objective is to finalize rebate agreements that deviate from the standard statutory exclusions, allowing for negotiated terms based on the specific characteristics and market conditions of Interferon beta-1b.
Typical requirements for such tenders include demonstrating the capacity to supply the specified pharmaceutical product, adherence to stringent quality and regulatory standards applicable within the European Union and Germany, and the ability to engage in complex rebate negotiations. Bidders will likely need to present detailed proposals outlining their proposed rebate structures, supply chain reliability, and commitment to patient access. The open-house model suggests that multiple entities may be able to enter into these agreements, provided they meet the defined criteria and terms.
This procurement is crucial for managing pharmaceutical expenditure within the German healthcare system while ensuring the availability of essential therapies.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 13, 2026. Last refreshed 8 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen has issued 36 procurement notices on BidsFactory, including 30 currently open and 2 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Water & Sanitation. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU) and DÖE Bekanntmachungsservice (Germany). Most recent publication: June 9, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
When does this tender close?
The submission deadline is May 31, 2028. You have 707 days left to prepare and submit your proposal to the contracting authority.
Who is the contracting authority?
This notice was issued by AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.